| Dimond Vision Clinic | |
|
1000 E Dimond Blvd Ste 101, Anchorage, AK 99515-2029 | |
| (907) 349-6932 | |
| (907) 349-6347 |
| Full Name | Dimond Vision Clinic |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1000 E Dimond Blvd Ste 101, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083730014 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 94 (Alaska) | Primary |
| Provider Name | Steven S Dobson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1982794434 PECOS PAC ID: 6901916436 Enrollment ID: I20110802000445 |
News Archive
A study published in the April issue of Journal of Vascular Surgery reports that women derive less benefit than men from elective endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA's). The research was done at The Vascular Group, The Institute for Vascular Health and Disease, Albany Medical College, The Center for Vascular Awareness Inc., in Albany, NY.
A study led by scientists at The Hospital for Sick Children (SickKids) reveals a new method of identifying drugs to treat children suffering from fatal cancers for which an effective treatment has not been found. Rather than developing a new drug from scratch, which is a complicated and time-consuming process, they tried a different approach: in the lab, they tested existing drugs on cancer stem cells from young patients with neuroblastoma, one of the common cancers of infants and children.
Reprogramming the rich connective tissue microenvironment of a liver cancer known as intrahepatic cholangiocarcinoma (ICC) inhibits its progression and resistance to standard chemotherapy in animal models, researchers from Massachusetts General Hospital have found.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
| Provider Name | Gary Michael Kjome |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1013055698 PECOS PAC ID: 0749396653 Enrollment ID: I20120216000372 |
News Archive
A study published in the April issue of Journal of Vascular Surgery reports that women derive less benefit than men from elective endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA's). The research was done at The Vascular Group, The Institute for Vascular Health and Disease, Albany Medical College, The Center for Vascular Awareness Inc., in Albany, NY.
A study led by scientists at The Hospital for Sick Children (SickKids) reveals a new method of identifying drugs to treat children suffering from fatal cancers for which an effective treatment has not been found. Rather than developing a new drug from scratch, which is a complicated and time-consuming process, they tried a different approach: in the lab, they tested existing drugs on cancer stem cells from young patients with neuroblastoma, one of the common cancers of infants and children.
Reprogramming the rich connective tissue microenvironment of a liver cancer known as intrahepatic cholangiocarcinoma (ICC) inhibits its progression and resistance to standard chemotherapy in animal models, researchers from Massachusetts General Hospital have found.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
| Provider Name | Nathan Frank |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1588812390 PECOS PAC ID: 4688726961 Enrollment ID: I20131231001000 |
News Archive
A study published in the April issue of Journal of Vascular Surgery reports that women derive less benefit than men from elective endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA's). The research was done at The Vascular Group, The Institute for Vascular Health and Disease, Albany Medical College, The Center for Vascular Awareness Inc., in Albany, NY.
A study led by scientists at The Hospital for Sick Children (SickKids) reveals a new method of identifying drugs to treat children suffering from fatal cancers for which an effective treatment has not been found. Rather than developing a new drug from scratch, which is a complicated and time-consuming process, they tried a different approach: in the lab, they tested existing drugs on cancer stem cells from young patients with neuroblastoma, one of the common cancers of infants and children.
Reprogramming the rich connective tissue microenvironment of a liver cancer known as intrahepatic cholangiocarcinoma (ICC) inhibits its progression and resistance to standard chemotherapy in animal models, researchers from Massachusetts General Hospital have found.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
| Provider Name | Stephanie Marie Berge |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1114413143 PECOS PAC ID: 4587911516 Enrollment ID: I20220419002476 |
News Archive
A study published in the April issue of Journal of Vascular Surgery reports that women derive less benefit than men from elective endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA's). The research was done at The Vascular Group, The Institute for Vascular Health and Disease, Albany Medical College, The Center for Vascular Awareness Inc., in Albany, NY.
A study led by scientists at The Hospital for Sick Children (SickKids) reveals a new method of identifying drugs to treat children suffering from fatal cancers for which an effective treatment has not been found. Rather than developing a new drug from scratch, which is a complicated and time-consuming process, they tried a different approach: in the lab, they tested existing drugs on cancer stem cells from young patients with neuroblastoma, one of the common cancers of infants and children.
Reprogramming the rich connective tissue microenvironment of a liver cancer known as intrahepatic cholangiocarcinoma (ICC) inhibits its progression and resistance to standard chemotherapy in animal models, researchers from Massachusetts General Hospital have found.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dimond Vision Clinic 1000 E Dimond Blvd Ste 101, Anchorage, AK 99515-2029 Ph: (907) 349-6932 | Dimond Vision Clinic 1000 E Dimond Blvd Ste 101, Anchorage, AK 99515-2029 Ph: (907) 349-6932 |
News Archive
A study published in the April issue of Journal of Vascular Surgery reports that women derive less benefit than men from elective endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA's). The research was done at The Vascular Group, The Institute for Vascular Health and Disease, Albany Medical College, The Center for Vascular Awareness Inc., in Albany, NY.
A study led by scientists at The Hospital for Sick Children (SickKids) reveals a new method of identifying drugs to treat children suffering from fatal cancers for which an effective treatment has not been found. Rather than developing a new drug from scratch, which is a complicated and time-consuming process, they tried a different approach: in the lab, they tested existing drugs on cancer stem cells from young patients with neuroblastoma, one of the common cancers of infants and children.
Reprogramming the rich connective tissue microenvironment of a liver cancer known as intrahepatic cholangiocarcinoma (ICC) inhibits its progression and resistance to standard chemotherapy in animal models, researchers from Massachusetts General Hospital have found.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
Dr. Gary Michael Kjome, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 E Dimond Blvd Ste 101, Anchorage, AK 99515 Phone: 907-349-6932 Fax: 907-349-6347 | |
Marko J Hrgovic, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4125 Debarr Rd, Anchorage, AK 99508 Phone: 907-269-9542 Fax: 907-269-9541 | |
Dr. Patrick Reber, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1345 W 9th Ave, Anchorage, AK 99501 Phone: 907-272-2557 Fax: 907-274-4932 | |
Makar Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4411 Business Park Blvd, Bldg. M Ste 10, Anchorage, AK 99503 Phone: 907-770-6652 Fax: 907-770-3668 | |
North Star Optical, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5710 Denali St, Anchorage, AK 99518 Phone: 907-444-8854 Fax: 888-612-1315 | |
Victoria Ann Blower, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 207 E Northern Lights Blvd, Ste 101, Anchorage, AK 99503 Phone: 907-272-9800 Fax: 907-277-1398 |